BioVie, Inc. (BIVI)
1.43
+0.05
(+3.62%)
USD |
NASDAQ |
Oct 30, 16:00
1.42
-0.01
(-0.70%)
Pre-Market: 20:00
BioVie Price to Book Value : 1.050 for Oct. 30, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 30, 2026 | 1.050 |
| October 29, 2026 | 1.014 |
| October 28, 2026 | 1.072 |
| October 27, 2026 | 1.058 |
| October 26, 2026 | 0.9768 |
| October 23, 2026 | 0.9107 |
| October 22, 2026 | 0.94 |
| October 21, 2026 | 0.9254 |
| October 20, 2026 | 0.9107 |
| October 19, 2026 | 1.006 |
| October 16, 2026 | 0.8813 |
| October 15, 2026 | 0.8299 |
| October 14, 2026 | 0.8519 |
| October 13, 2026 | 0.8813 |
| October 12, 2026 | 0.9694 |
| October 09, 2026 | 1.021 |
| October 08, 2026 | 0.94 |
| October 07, 2026 | 1.028 |
| October 06, 2026 | 1.058 |
| October 05, 2026 | 1.058 |
| October 02, 2026 | 1.072 |
| October 01, 2026 | 1.080 |
| September 30, 2026 | 1.116 |
| September 29, 2026 | 1.131 |
| September 28, 2026 | 1.131 |
| Date | Value |
|---|---|
| September 25, 2026 | 1.179 |
| September 24, 2026 | 1.182 |
| September 23, 2026 | 1.197 |
| September 22, 2026 | 1.197 |
| September 21, 2026 | 1.197 |
| September 18, 2026 | 1.182 |
| September 17, 2026 | 1.307 |
| September 16, 2026 | 1.263 |
| September 15, 2026 | 1.285 |
| September 14, 2026 | 1.506 |
| September 11, 2026 | 1.417 |
| September 10, 2026 | 1.403 |
| September 09, 2026 | 1.447 |
| September 08, 2026 | 1.520 |
| September 04, 2026 | 1.469 |
| September 03, 2026 | 1.491 |
| September 02, 2026 | 1.491 |
| September 01, 2026 | 1.645 |
| August 31, 2026 | 1.674 |
| August 28, 2026 | 1.586 |
| August 27, 2026 | 1.608 |
| August 26, 2026 | 1.550 |
| August 25, 2026 | 1.535 |
| August 24, 2026 | 1.572 |
| August 21, 2026 | 1.432 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 21.55 |
| Anika Therapeutics, Inc. | 2.042 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.014 |
Price to Book Value Related Metrics
| Price | 1.43 |
| Earnings Yield | -223.6% |
| Market Cap | 10.79M |